Research group: Big pharmaceutical companies ‘pay to delay’ generic drugs

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

DENVER -- A Colorado group says some big pharmaceutical corporations are responsible for keeping cheaper forms of medicine off the market because of deals they make with their generic drug competitors.

The Colorado Public Interest Research Group says the deals sometimes delay generic forms of popular medications from hitting the market for 5 to 9 years.

Watch Dave Young's video report for more information about this.